Analysis of publically available RNA-Seq data [19] show that ST6GalNAc1 exon 2 is detected in both clinical prostate cancer and in a number of additional cancers, particularly lung cancer (Supplementary Figure 5C). Here, ST6GALNAC1 is linked to lung carcinoma.